Cryptolepine is a powerful substance found in the medicinal plant known as Cryptolepis sanguinolenta or Nibima.
It has shown great effectiveness in fighting against various bacteria and viruses, including malaria, hepatitis B, and even covid-19.
A recent study led by Dr. Patrick Narkwa from the Department of Clinical Microbiology at KNUST focused on exploring how cryptolepine affects cell interactions in human embryonic kidney cells.
Disordered cell interactions can lead to serious diseases such as cancer.
The results of the study, published in the Journal of Science and Technology, revealed that cryptolepine has the ability to regulate cell interactions in an orderly manner.
This finding supports the pharmacological and biological effects of cryptolepine in different types of cells.
According to the report, “The results from our studies support the pharmaco-biological effects of cryptolepine in different cells.”
This research sheds light on the potential of cryptolepine as a valuable resource in the fight against various diseases.
It is important to note that the views and statements expressed in this article do not necessarily reflect the views or policies of Multimedia Group Limited.
